Relay Therapeutics Inc. (NASDAQ: RLAY) closed the day trading at $9.00 down -3.95% from the previous closing price of $9.37. In other words, the price has decreased by -$0.37 from its previous closing price. On the day, 1112403 shares were traded. RLAY stock price reached its highest trading level at $9.63 during the session, while it also had its lowest trading level at $8.87.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Ratios:
For a better understanding of RLAY, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.40 and its Current Ratio is at 12.40. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 28 when Bergstrom Donald A sold 2,683 shares for $11.80 per share. The transaction valued at 31,659 led to the insider holds 237,904 shares of the business.
Catinazzo Thomas sold 1,693 shares of RLAY for $19,977 on Jul 28. The Chief Financial Officer now owns 146,136 shares after completing the transaction at $11.80 per share. On Jul 28, another insider, Adams Brian, who serves as the Chief Legal Officer of the company, sold 1,628 shares for $11.80 each. As a result, the insider received 19,210 and left with 131,887 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RLAY now has a Market Capitalization of 1.10B and an Enterprise Value of 283.34M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1252.60 while its Price-to-Book (P/B) ratio in mrq is 1.35. Its current Enterprise Value per Revenue stands at 300.78 whereas that against EBITDA is -0.76.
Stock Price History:
Over the past 52 weeks, RLAY has reached a high of $24.93, while it has fallen to a 52-week low of $9.18. The 50-Day Moving Average of the stock is 11.05, while the 200-Day Moving Average is calculated to be 14.23.
Shares Statistics:
Over the past 3-months, RLAY traded about 1.06M shares per day on average, while over the past 10 days, RLAY traded about 1.33M shares per day. A total of 121.68M shares are outstanding, with a floating share count of 116.96M. Insiders hold about 1.20% of the company’s shares, while institutions hold 110.76% stake in the company. Shares short for RLAY as of Aug 30, 2023 were 19.89M with a Short Ratio of 19.89M, compared to 19.63M on Jul 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 16.28% and a Short% of Float of 21.42%.
Earnings Estimates
Current recommendations for the stock of the company come from 12 analysts. On average, analysts expect EPS of -$0.84 for the current quarter, with a high estimate of -$0.68 and a low estimate of -$0.92, while EPS last year was -$0.76. The consensus estimate for the next quarter is -$0.87, with high estimates of -$0.69 and low estimates of -$0.95.
Analysts are recommending an EPS of between -$2.74 and -$3.49 for the fiscal current year, implying an average EPS of -$3.28. EPS for the following year is -$3.5, with 14 analysts recommending between -$2.86 and -$4.16.